Trends in medication treatment for ADHD.
Lon Castle1, Ronald E Aubert, Robert R Verbrugge
1Medco Health Solutions Inc., 100 Parsons Pond Drive, Franklin Lakes, NJ 07417, USA. lon_castle@medco.com
Journal of Attention Disorders
|April 24, 2007
Summary
ADHD medication use significantly increased from 2000-2005, with notable growth in adult and female populations. This trend reflects improved identification of Attention Deficit Hyperactivity Disorder (ADHD) in these groups.
Area of Science:
- Pharmacology
- Epidemiology
- Public Health
Background:
- Attention Deficit Hyperactivity Disorder (ADHD) diagnosis and treatment have evolved.
- Understanding demographic trends in ADHD medication use is crucial for public health.
- Previous research has focused on pediatric populations, with less emphasis on adult trends.
Purpose of the Study:
- To analyze demographic trends in ADHD medication utilization among adult and pediatric populations.
- To quantify the prevalence of ADHD treatment across different age groups and genders.
- To identify changes in ADHD drug use patterns between 2000 and 2005.
Main Methods:
- Utilized pharmacy claims data from a large cohort of commercially insured Americans.
- Measured ADHD treatment prevalence and specific drug usage patterns.
- Analyzed data spanning the years 2000 to 2005.
Main Results:
- In 2005, 4.4% of children (0-19) and 0.8% of adults (20+) used ADHD medications.
- Treatment rates were higher in boys (6.1%) than girls (2.6%), with similar rates for adult men and women (0.8%).
- Overall ADHD treatment prevalence grew by 11.8% annually, with faster growth rates observed in adults, women, and girls.
Conclusions:
- The rapid increase in ADHD medication use is attributed to better identification of the disorder in adult and female patients.
- This suggests a broadening scope of ADHD diagnosis beyond traditional pediatric male cases.
- Continued monitoring of demographic trends in ADHD treatment is warranted.
More Related Videos
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...